North America
Court Grants Natera Injunction Against Invitae, ArcherDx in Use of Patented Products
The defendants are barred from using Personalized Cancer Monitoring products except for ongoing clinical trials, studies undergoing peer review, and quality control.
In Brief This Week: ARUP Laboratories; Hologic; Thermo Fisher Scientific; More
News items for the week of Nov. 27, 2023
Claris GenomiX Seeks Commercialization Partners for Cancer Subtyping Tests, Starting With CRC
Premium
The University of Notre Dame spinout has developed molecular subtyping tests for colorectal and other cancers, and seeks partners to bring them to the clinic.
The agency has suggested approaches like third-party review would help manage the expected influx of submissions, but labs and vendors remain concerned.
US Government to Distribute Millions of Free COVID-19 Tests to Schools
The rapid antigen tests will be made available for free to all traditional and charter local education agencies across the US.